(Q34473008)

2 August 2017

Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study (English)

1 reference

2 August 2017

1 reference

1 reference

Dimitris Trichopoulos

8

object named as

Trichopoulos D

1 reference

2 August 2017

1

Wolk A

1 reference

2 August 2017

7

Adami HO

1 reference

2 August 2017

5

Signorello LB

1 reference

2 August 2017

Mantzoros CS

2

1 reference

2 August 2017

Andersson SO

3

1 reference

2 August 2017

Bergström R

4

1 reference

2 August 2017

Lagiou P

6

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 June 1998

1 reference

Journal of the National Cancer Institute

2 August 2017

1 reference

2 August 2017

90

1 reference

2 August 2017

911-915

1 reference

2 August 2017

12

1 reference

Review of the role of androgenic hormones in the epidemiology of benign prostatic hyperplasia and prostate cancer

2 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.12.911

Prospective study of sex hormone levels and risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.12.911

Insulin-like growth factor I: action and receptor characterization in human prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.12.911

Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.12.911

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.12.911

Serum pituitary and sex steroid hormone levels in the etiology of prostatic cancer--a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.12.911

Serum and follicular fluid levels of insulin-like growth factor I (IGF-I), IGF-II, and IGF-binding protein-1 and -3 during the normal menstrual cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.12.911

Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.12.911

Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.12.911

Insulin-Like Growth Factors (IGFs), IGF Receptors, and IGF-Binding Proteins in Primary Cultures of Prostate Epithelial Cells*

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.12.911

Insulin-like growth factor (IGF) system components in human prostatic cancer cell-lines: LNCaP, DU145, and PC-3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.12.911

Height and cancer risk in a network of case-control studies from northern Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.12.911

Adult height and incidence of cancer in male physicians (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.12.911

Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.12.911

21 January 2018

Identifiers

DOI

10.1093/JNCI/90.12.911

1 reference

2 August 2017

1 reference